L A M Y (PK) Aktie - LMMY

L A M Y (PK) (LMMY) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

0,4381

( - )

Gebot

0,18

Fragen

0,47

Volumen

0,00 Tagesbereich 0,00

0,0625 52-Wochen-Bereich 0,94

Marktkapitalisierung

23M

Handelsende

0,4381

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

US$ 1.455

Ausgegebene Aktien

52.500.000

Dividendenrendite (LTM)

Kurs-Gewinn-Verhältnis

-56,91

Gewinn pro Aktie (EPS)

-0,01

Erlöse (LTM)

Nettogewinn (LTM)

-80,16k

LAMY designs, develops, and operates an eLearning and gaming marketplace platform. It offers TwoPlus1, an educational video game that provides financial knowledge and resource management to children. The company was incorporated in 2022 and is based in New York, New York. LAMY designs, develops, and operates an eLearning and gaming marketplace platform. It offers TwoPlus1, an educational video game that provides financial knowledge and resource management to children. The company was incorporated in 2022 and is based in New York, New York.

Sektor

Branche

Hauptsitz

New York, United States

Gegründet

2026

L A M Y (PK) is listed in the sector of the OTC Markets with ticker LMMY. The last closing price for L A M Y (PK) was US$0,44. Over the last year, L A M Y (PK) shares have traded in a share price range of US$ 0,0625 to US$ 0,94.

L A M Y (PK) currently has 52.500.000 shares in issue. The market capitalisation of L A M Y (PK) is US$23,00 million. L A M Y (PK) has a price to earnings ratio (PE ratio) of -56.91.

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0.4381	0.4381	0.4381	500	0.4381	CS
4	0.0781	21.6944444444	0.36	0.4381	0.36	1477	0.37205389	CS
12	0.0481	12.3333333333	0.39	0.47	0.315	1490	0.40428267	CS
26	0.0681	18.4054054054	0.37	0.5	0.26	1688	0.39292695	CS
52	0.1881	75.24	0.25	0.94	0.0625	3059	0.39099262	CS
156	0.2381	119.05	0.2	16	0.06	10102	3.87305385	CS
260	0.2381	119.05	0.2	16	0.06	10102	3.87305385	CS

LMMY - Frequently Asked Questions (FAQ)

What is the current L A M Y (PK) share price?

The current share price of L A M Y (PK) is US$ 0,4381

How many L A M Y (PK) shares are in issue?

L A M Y (PK) has 52.500.000 shares in issue

What is the market cap of L A M Y (PK)?

The market capitalisation of L A M Y (PK) is USD 23M

What is the 1 year trading range for L A M Y (PK) share price?

L A M Y (PK) has traded in the range of US$ 0,0625 to US$ 0,94 during the past year

What is the PE ratio of L A M Y (PK)?

The price to earnings ratio of L A M Y (PK) is -56,91

What is the registered address of L A M Y (PK)?

The registered address for L A M Y (PK) is 201 Allen Street, New York, New York, 10002

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

L A M Y (PK) (LMMY)

L A M Y (PK) (LMMY) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über L A M Y (PK)

LMMY Neueste Nachrichten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

LMMY - Frequently Asked Questions (FAQ)

LMMY Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen